首页> 外文会议>Microbial engineering >OPTIMIZATION OF ISOPRENE PRODUCTION USING A METABOLICALLY ENGINEERED ESCHERICHIA COLI
【24h】

OPTIMIZATION OF ISOPRENE PRODUCTION USING A METABOLICALLY ENGINEERED ESCHERICHIA COLI

机译:用代谢工程化的大肠杆菌优化异戊二烯的生产

获取原文
获取原文并翻译 | 示例

摘要

The volatile C5 hydrocarbon, isoprene is an important platform chemical, which has been used in the manufacture of synthetic rubber for tires and also has the potential for various other applications such as elastomers and adhesives. Moreover, isoprene is convertible to biofuel blend stocks such as C10 gasoline, C15 diesel, and jet fuels because of its higher energy content than other biofuels. Although isoprene is currently derived from petroleum, its sustainable supply has been suffered from price fluctuation of crude oil, high refining cost and energy consumption, and low recovery yield of pure isoprene. As an alternative, the biologically produced isoprene (bio-isoprene) has been developed rapidly for the last decade. Bio-isoprene is synthesized from dimethylallyl diphosphate (DMAPP), which is derived from mevalonate (MVA) pathway or the methylerythritol phosphate (MEP) pathway, by isoprene synthase. In this study, metabolic engineering for enhanced production of bio-isoprene was performed by deletion of relevant genes and optimization of culture condition. In comparison of isoprene production between E.coli DH5a and MG1655, lower isoprene production was observed in MG1655. The lower isoprene production in E. coli MG1655 was ascribed to the presence of recA gene which is absent in the DH5α strain. The deletion of recA gene in E.coli MG1655 allows higher isoprene production than E. coli DH5α. Moreover, the optimized expression of isoprene synthesis pathway with 0.03mM IPTG induction enhanced the isoprene production up to 2,850 mg/L. Overall, isoprene production through the optimization was improved by 28.5-fold compared to the initial production of MG1655 strain.
机译:挥发性的C5碳氢化合物异戊二烯是重要的平台化学品,已用于制造轮胎用合成橡胶,并且还具有用于弹性体和粘合剂等各种其他应用的潜力。此外,由于异戊二烯的能量含量高于其他生物燃料,因此可以转化为生物燃料混合原料,例如C10汽油,C15柴油和喷气燃料。尽管异戊二烯目前来自石油,但其可持续供应受到原油价格波动,高炼制成本和能源消耗以及纯异戊二烯回收率低的困扰。作为替代方案,生物生产的异戊二烯(生物异戊二烯)在过去十年中发展迅速。生物异戊二烯是通过异戊二烯合酶由二甲烯丙基二磷酸酯(DMAPP)合成的,该二甲基烯丙基二磷酸酯是从甲羟戊酸酯(MVA)途径或甲基赤藓糖醇磷酸酯(MEP)途径衍生的。在这项研究中,通过缺失相关基因和优化培养条件来进行代谢工程,以提高生物异戊二烯的产量。通过比较大肠杆菌DH5a和MG1655的异戊二烯产量,可以发现MG1655的异戊二烯产量较低。大肠杆菌MG1655中异戊二烯产量较低的原因是在DH5α菌株中不存在recA基因。大肠杆菌MG1655中recA基因的缺失使异戊二烯的产量高于大肠杆菌DH5α。此外,通过0.03mM IPTG诱导,异戊二烯合成途径的优化表达将异戊二烯的产量提高到2,850 mg / L。总体而言,与初始生产的MG1655菌株相比,通过优化获得的异戊二烯产量提高了28.5倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号